Fixes Book Closure for AGM
Natco Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2014 to September 27, 2014 (both days inclusive) for the purpose of 31st Annual General Meeting (AGM) of the Company to be held on September 27, 2014. Financial Results with Results Press Release & Limited Review for June 30, 2014
Natco Pharma Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended June 30, 2014. Outcome of Board Meeting
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2014, inter alia, taken on record and considered the following items of business:1. Board Constituted the Corporate Social Responsibility Committee of Directors.2. Board renamed and re-constituted the Investors Grievance Committee into Stakeholders Relationship Committee and Remuneration Committee into Nomination and Remuneration Committee.... Closure of Trading Window
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2014, inter alia, to consider the unaudited financial Results for the quarter ended June 30, 2014, convening of 31st Annual General Meeting and related matters etc.Further, note that Trading Window for dealing in the securities of the Company will be closed from July 31, 2014 to August 14, 2014 (both days inclusive).... Natco pleased with Bombay High Court decision to uphold Compulsory License on Nexavar issued to the Company
Natco Pharma Ltd has informed BSE regarding a Press Release dated July 15, 2014, titled "Natco pleased with Bombay High Court decision to uphold Compulsory License on Nexavar issued to the Company" Shareholding Pattern For June 30, 2014
Natco Pharma Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Group Employees Welfare Trust has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neelima Sita Nannapaneni has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
Neelima Nannapaneni Trust & Neelima Sita Nannapaneni has submitted the disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992